Co-Diagnostics, Inc. (Co-Dx)
Co-Diagnostics develops innovative solutions for detection of infectious disease, liquid biopsy for cancer screening, and agribio applications. Our proprietary CoPrimer technology excels in disease detection, multiplexing, and life sciences research through enhanced detection of genetic material. Our EIKON At Home and Point of Care platform is designed to provide fast, inexpensive, and accurate PCR test results, utilizing proprietary chemistry and instrumentation.